DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Phosphate binder
Phosphate binder
How to Take Your Phosphate Binders
New Brunswick Drug Plans Formulary
In-Class Targeted Therapies That Advance Patient Care
Phosphate Binders
Dorset Medicines Advisory Group
Nephrology II BONE METABOLISM and DISEASE in CHRONIC KIDNEY DISEASE
Case Report Sevelamer Carbonate Crystal-Induced Colitis
Phosphate, Microbiota and CKD
(October), 2005
Why Does It Matter When I Take My Phosphate Binders?
Effectiveness of Self-Adjusted Phosphate Binder Dose According to Dietary Phosphate Content Method in Improving Hyperphosphatemia Among Hemodialysis Patients
The Effects of Colestilan Versus Placebo and Sevelamer in Patients with CKD 5D and Hyperphosphataemia: a 1-Year Prospective Randomized Study
Calcium and Phosphate Balance in CKD
Passionately Committed to Bettering the Lives of Patients with Kidney and Cardiovascular Diseases
Therapeutic Class Overview Electrolyte Depleters
DDM 4 Case 2 Group 8
January 29, 2013 News Release Bindren ® Granted Marketing
Therapeutic Class Overview Electrolyte Depleters
Top View
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
22127 S015 and 22318 S008 Priority Or Standard Priority Submit Date(S
(Sevelamer) with a Calcium- Containing Phosphate Binder (Calcium Acetate) in the Treatment of Hyperphosphatemia in Children with Chronic Renal Failure
Phosphate Binders (Non-Calcium, Non-Aluminum) Lanthanum Carbonate, Sevelamer Carbonate, Ferric Citrate, Sucroferric Oxyhydroxide
Sevelamer Carbonate Tablets (8-Week Cross-Over) Study Were: Nausea Renvela (Sevelamer Carbonate) Tablet, Film Coated for Oral Use (3%) and Vomiting (3%)
Innovationsreport 2017
Patiromer–An Oral Calcium-Loaded Potassium Binder: Kalirrhea with Calciuresis
Phosphate Binders
Drug Crystal-Related Gastrointestinal Complications Involve Crystal-Induced Release of Neutrophil and Monocyte Extracellular Traps
Medication Coverage Policy
Tumor Lysis Syndrome (TLS) in Adult Patients
A13-15 Colestilan – Benefit Assessment According 1 to § 35A Social Code Book V
Effects of the Potassium-Binding Polymer Patiromer on Markers of Mineral Metabolism
(Sevelamer Carbonate) Is Indicated for the Control of Serum Phosphorus in Adults and Children 6 Years of Age and Older with Chronic Kidney Disease (CKD) on Dialysis
Phosphate Binders Review 02/10/2009
No. Reference Year Country Denominator
(KHK7791) for Hyperphosphatemia in Patients on Hemodialysis and Peritoneal Dialysis in Japan
Exploring Co-Dispensed Drug Use in Patients on Sevelamer Or Polystyrene Sulfonate to Identify Potential Novel Binding Interactions: a Cross Sectional in Silico Study
Phosphate Binders in Patients with Chronic Kidney Disease
Phosphate Binders Review – September 2020 Page 2 | Proprietary Information
New Brunswick Drug Plans Formulary
Effect of Calcium Acetate/Magnesium Carbonate in the Treatment of Hyperphosphataemia in Dialysis Patients in Real Clinical Practice
Office of Clinical Pharmacology Integrated Review
Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Maintenance Hemodialysis: Results of the CARE Study
The Diet and Haemodialysis Dyad: Three Eras, Four Open Questions and Four Paradoxes